Pedro Cruz-Nova

7PUBLICATIONS
15CO-AUTHORS
Radiation therapyGene and molecular therapyMolecular targetsPredictive and prognostic markersMicro- and nanosystems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2025
Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose.

Guillermina Ferro-Flores, Erika Azorín-Vega, Blanca Ocampo-García

|Apr 27, 2024
68Ga-DOTA-D-Alanine-BoroPro Radiotracer for Imaging of the Fibroblast Activation Protein in Malignant and Non-Malignant Diseases.

Diana Trujillo-Benítez, Myrna Luna-Gutiérrez, José G Aguirre-De Paz

|Dec 23, 2023
99mTc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe.

Guillermina Ferro-Flores, Blanca Ocampo-García, Pedro Cruz-Nova

|Dec 09, 2023
225Ac-iPSMA-RGD for Alpha-Therapy Dual Targeting of Stromal/Tumor Cell PSMA and Integrins.

Blanca Ocampo-García, Pedro Cruz-Nova, Nallely Jiménez-Mancilla

|Aug 12, 2023
Synthesis and Evaluation of 177Lu-DOTA-PD-L1-i and 225Ac-HEHA-PD-L1-i as Potential Radiopharmaceuticals for Tumor Microenvironment-Targeted Radiotherapy.

Myrna Luna-Gutiérrez, Pedro Cruz-Nova, Nallely Jiménez-Mancilla

|Dec 11, 2022
Toxicity Assessment of [177Lu]Lu-iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes.

Tania Hernández-Jiménez, Pedro Cruz-Nova, Alejandra Ancira-Cortez

Pageof 2